AP393A - Substituted pipecolinic and acid derivatives as HIV protease inhibitors. - Google Patents
Substituted pipecolinic and acid derivatives as HIV protease inhibitors. Download PDFInfo
- Publication number
- AP393A AP393A APAP/P/1993/000495A AP9300495A AP393A AP 393 A AP393 A AP 393A AP 9300495 A AP9300495 A AP 9300495A AP 393 A AP393 A AP 393A
- Authority
- AP
- ARIPO
- Prior art keywords
- butyl
- tert
- hydroxy
- carboxamide
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85071692A | 1992-03-13 | 1992-03-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9300495A0 AP9300495A0 (en) | 1993-04-30 |
| AP393A true AP393A (en) | 1995-08-07 |
Family
ID=25308925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1993/000495A AP393A (en) | 1992-03-13 | 1993-03-10 | Substituted pipecolinic and acid derivatives as HIV protease inhibitors. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5807870A (pl) |
| EP (1) | EP0560268B1 (pl) |
| JP (1) | JP3258422B2 (pl) |
| KR (1) | KR950700253A (pl) |
| AP (1) | AP393A (pl) |
| AT (1) | ATE116640T1 (pl) |
| AU (1) | AU670582B2 (pl) |
| CA (1) | CA2131185C (pl) |
| CZ (1) | CZ285589B6 (pl) |
| DE (1) | DE69300043T2 (pl) |
| DK (1) | DK0560268T3 (pl) |
| ES (1) | ES2066623T3 (pl) |
| FI (1) | FI944217L (pl) |
| GR (1) | GR3015622T3 (pl) |
| HU (2) | HUT70617A (pl) |
| IL (1) | IL105035A (pl) |
| NO (1) | NO302570B1 (pl) |
| NZ (1) | NZ251267A (pl) |
| OA (1) | OA10092A (pl) |
| PH (1) | PH30734A (pl) |
| PL (1) | PL176362B1 (pl) |
| RU (1) | RU2140911C1 (pl) |
| SK (1) | SK280161B6 (pl) |
| WO (1) | WO1993018003A1 (pl) |
| ZA (1) | ZA931776B (pl) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9306058A (pt) | 1992-03-11 | 1997-11-18 | Narhex Ltd | Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos |
| US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| DE69333270T2 (de) | 1992-03-11 | 2004-08-05 | Narhex Ltd. | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
| US5559256A (en) * | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
| DE122007000045I2 (de) | 1992-08-25 | 2011-07-21 | Gd Searle Llc Gd Searle Llc | Darunavir oder pharmazeutisch vertragliche Salze, Hydroxyethylaminosulfonamide verwendbar als InhibiEster oder Prodrugs davon. toren retroviraler Proteasen. |
| US5846993A (en) * | 1992-12-22 | 1998-12-08 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| EP0610745A3 (en) * | 1993-02-09 | 1994-09-28 | Miles Inc | Novel aminomethylene derivatives as immunosuppressants. |
| IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
| US5527829A (en) * | 1994-05-23 | 1996-06-18 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| CA2137406C (en) * | 1994-12-06 | 2005-09-13 | Pierre Louis Beaulieu | Process for key intermediates for hiv protease inhibitors |
| US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
| US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| US5883252A (en) * | 1996-01-26 | 1999-03-16 | Vertex Pharmaceuticals Incorporated | Aspartyl protease inhibitors |
| US5925759A (en) | 1996-09-05 | 1999-07-20 | Agouron Pharmaceuticals, Inc. | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
| US5705647A (en) * | 1996-09-05 | 1998-01-06 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
| US5962725A (en) | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
| US6232333B1 (en) | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
| US6001851A (en) * | 1997-03-13 | 1999-12-14 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US6084107A (en) * | 1997-09-05 | 2000-07-04 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
| US6251906B1 (en) | 1998-05-15 | 2001-06-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| ES2676151T3 (es) | 2000-01-19 | 2018-07-17 | Abbvie Inc. | Formulaciones farmacéuticas mejoradas |
| US6992081B2 (en) | 2000-03-23 | 2006-01-31 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| AU2001252958A1 (en) * | 2000-03-23 | 2001-10-03 | Elan Pharmaceuticals, Inc. | Compounds and methods to treat alzheimer's disease |
| US20030096864A1 (en) * | 2000-06-30 | 2003-05-22 | Fang Lawrence Y. | Compounds to treat alzheimer's disease |
| CA2410680A1 (en) * | 2000-06-30 | 2002-01-10 | Elan Pharmaceuticals, Inc. | Compounds to treat alzheimer's disease |
| EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| CA2452039A1 (en) * | 2001-06-27 | 2003-01-09 | Elan Pharmaceuticals, Inc. | Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease |
| US20070213407A1 (en) * | 2001-06-29 | 2007-09-13 | Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc | Compounds to treat Alzheimer's disease |
| JP4482883B2 (ja) | 2003-05-22 | 2010-06-16 | リードケミカル株式会社 | 抗ウイルス作用を有する化合物およびその配合剤 |
| BRPI0510746A (pt) * | 2004-06-10 | 2007-11-20 | Univ Michigan State | sìntese de caprolactama a partir de lisina |
| ES2426345T3 (es) * | 2005-07-20 | 2013-10-22 | Eli Lilly And Company | Compuesto unidos en posición 1-amino |
| JP5410996B2 (ja) * | 2007-02-20 | 2014-02-05 | ボード オブ トラスティーズ オブ ミシガン ステイト ユニバーシティ | カプロラクタム製造のための触媒的脱アミノ化 |
| WO2008112289A2 (en) | 2007-03-12 | 2008-09-18 | Nektar Therapeutics | Oligomer-protease inhibitor conjugates |
| WO2009114151A1 (en) | 2008-03-12 | 2009-09-17 | Nektar Therapeutics | Oligomer-amino acid and olgomer-atazanavir conjugates |
| EP2318373A1 (en) * | 2008-07-24 | 2011-05-11 | Draths Corporation | Methods of making cyclic amide monomers, and related derivatives and methods |
| EP2440249A2 (en) | 2009-06-12 | 2012-04-18 | Nektar Therapeutics | Covalent conjugates comprising a protease inhibitor, a water-soluble, non-peptidic oligomer and a lipophilic moiety |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0346847A2 (en) * | 1988-06-13 | 1989-12-20 | F. Hoffmann-La Roche Ag | Amino acid derivatives |
| EP0432695A2 (en) * | 1989-12-11 | 1991-06-19 | F. Hoffmann-La Roche Ag | Amino acid derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0264106B1 (en) * | 1986-10-14 | 1994-03-16 | Banyu Pharmaceutical Co., Ltd. | 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use |
| JPH07106992B2 (ja) * | 1988-06-13 | 1995-11-15 | 三菱石油株式会社 | 2,6―ジメチルナフタレンの分離方法 |
| EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
| GB8927915D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Novel alcohols |
| IE920414A1 (en) * | 1991-02-08 | 1992-08-12 | Sankyo Co | New beta-amino-alpha-hydroxycarboxylic acids and their use |
| MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
| ZA931777B (en) * | 1992-03-13 | 1993-09-23 | Bio Mega Boehringer Ingelheim | Substituted pyrrolidine derivatives as HIV protease inhibitors. |
| IL110255A (en) * | 1993-07-16 | 1998-12-06 | Merck & Co Inc | Formation and resolution of 2-tert-butylcarboxamido-piperazine |
| US5480887A (en) * | 1994-02-02 | 1996-01-02 | Eli Lilly And Company | Protease inhibitors |
| GB2292146A (en) * | 1994-08-11 | 1996-02-14 | Merck & Co Inc | HIV protease inhibitors useful for the treatment of AIDS |
-
1993
- 1993-03-09 AT AT93103712T patent/ATE116640T1/de active
- 1993-03-09 DK DK93103712.1T patent/DK0560268T3/da active
- 1993-03-09 EP EP93103712A patent/EP0560268B1/en not_active Expired - Lifetime
- 1993-03-09 ES ES93103712T patent/ES2066623T3/es not_active Expired - Lifetime
- 1993-03-09 DE DE69300043T patent/DE69300043T2/de not_active Expired - Lifetime
- 1993-03-10 AP APAP/P/1993/000495A patent/AP393A/en active
- 1993-03-11 PH PH45862A patent/PH30734A/en unknown
- 1993-03-12 RU RU94040841A patent/RU2140911C1/ru active
- 1993-03-12 SK SK1090-94A patent/SK280161B6/sk unknown
- 1993-03-12 HU HU9402613A patent/HUT70617A/hu unknown
- 1993-03-12 NZ NZ251267A patent/NZ251267A/en unknown
- 1993-03-12 CA CA002131185A patent/CA2131185C/en not_active Expired - Lifetime
- 1993-03-12 CZ CZ942232A patent/CZ285589B6/cs not_active IP Right Cessation
- 1993-03-12 FI FI944217A patent/FI944217L/fi unknown
- 1993-03-12 PL PL93305166A patent/PL176362B1/pl unknown
- 1993-03-12 AU AU38808/93A patent/AU670582B2/en not_active Ceased
- 1993-03-12 IL IL105035A patent/IL105035A/xx not_active IP Right Cessation
- 1993-03-12 ZA ZA931776A patent/ZA931776B/xx unknown
- 1993-03-12 WO PCT/CA1993/000096 patent/WO1993018003A1/en not_active Ceased
- 1993-03-15 JP JP05414293A patent/JP3258422B2/ja not_active Expired - Fee Related
-
1994
- 1994-08-05 OA OA60550A patent/OA10092A/en unknown
- 1994-09-12 NO NO943383A patent/NO302570B1/no unknown
- 1994-09-13 KR KR1019940703190A patent/KR950700253A/ko not_active Abandoned
-
1995
- 1995-03-27 GR GR950400700T patent/GR3015622T3/el unknown
- 1995-06-23 HU HU95P/P00429P patent/HU211854A9/hu unknown
-
1996
- 1996-12-11 US US08/763,464 patent/US5807870A/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0346847A2 (en) * | 1988-06-13 | 1989-12-20 | F. Hoffmann-La Roche Ag | Amino acid derivatives |
| EP0432695A2 (en) * | 1989-12-11 | 1991-06-19 | F. Hoffmann-La Roche Ag | Amino acid derivatives |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0560268B1 (en) | Substituted pipecolinic acid derivatives as HIV protease inhibitors | |
| DE69316223T2 (de) | Sulfonylalkanoylaminohydroxyethylaminosulfonamide verwendbar als retrovirale protease-inhibitoren | |
| DE69319351T2 (de) | Hydroxyethylaminosulfamidsäure-derivate verwendbar als inhibitoren retroviraler proteasen | |
| US5552405A (en) | Substituted pyrrolidine derivatives as HIV protease inhibitors | |
| US5545640A (en) | Protease inhibiting succinic acid derivatives | |
| US5614533A (en) | Substituted pipecolinic acid derivatives as HIV protease inhibitors | |
| DE69326077T2 (de) | Sulfonylalkanoylaminohydroxyethylaminosulfaminsäuren verwendbar als inhibitoren retroviraler proteasen | |
| HUP9803040A2 (hu) | Tiazolszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| US20050090546A1 (en) | Aspartic protease inhibitors | |
| CA2036397C (en) | Hiv protease inhibitors containing derived amino acid units | |
| Budt et al. | HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diols | |
| EP0687675A2 (en) | Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof | |
| US5696134A (en) | Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof | |
| CN1096292A (zh) | 取代的吡咯烷衍生物用作hiv蛋白抑制剂 | |
| CN1096293A (zh) | 用作hiv蛋白酶抑制剂的取代2-哌啶酸衍生物 | |
| JP2004292456A (ja) | 新規なヒドロキシカルボン酸誘導体 |